[ad_1]
OR Gamaleya Institute, responsible for the development of the Russian vaccine SputnikV, responded to the tute of the Argentine president Alberto Fernndez, in which he announced that he had tested positive for COVID-19, reinforcing the efficacy of the vaccine. Fernández had taken both doses of Sputnik in January and February.
“We are saddened to hear this (the Argentine president’s announcement of the infection). SputnikV is 91.6% effective against infection and 100% effective against rare cases. If the infection is indeed confirmed and occurs, vaccination guarantees a rapid recovery without symptoms. We wish him (Fernández) a speedy recovery, “said the Institute in a post on Twitter.
In a CNN interview that aired this morning, doctor Gonzalo Vecina Neto, former president of Anvisa, stated that in 35 countries Sputnik has not yet received approval from health agencies. Wanted by the report, the institute did not confirm this information, but noted that Sputnik is approved for use in 59 countries and that it is second in the world in terms of approvals by government regulatory agencies.
